Amorolfine is a broad spectrum antimycotic. Amorolfine belongs to a new chemical class, and its fungicidal action is based on an alteration of the fungal cell membrane targeted primarily on sterol biosynthesis. The ergosterol content is reduced, and at the same time unusual sterically nonplanar sterols accumulate.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Amorolfine is the active ingredient of these drugs:
Hong Kong
Austria
Australia
Hong Kong
Hong Kong Ireland
Brazil
Lithuania
Austria
Lithuania
Lithuania
Australia Austria Brazil Cyprus France
Spain
Hong Kong
Brazil
Australia
Spain
United Kingdom
Brazil
Brazil
Hong Kong
Ireland
Brazil
Hong Kong
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):